Overview

An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease

Status:
RECRUITING
Trial end date:
2029-02-28
Target enrollment:
Participant gender:
Summary
This exploratory trial is to prove the tolerability and safety of VGN-R08b to treat infants with type II Gaucher disease.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator:
Shanghai Vitalgen BioPharma Co., Ltd.